Drug shortages have become par for the course in the waning months of 2022, first plaguing the popular ADHD medicine Adderall, then the common antibiotic amoxicillin. Now, generics of Roche’s influenza stalwart Tamiflu (oseltamivir) are in short supply.
Teva, Zydus, Macleods, Camber and Amneal are struggling to supply a range of copycat Tamiflu doses in both capsule and powder suspension formats, the American Society of Health-System Pharmacists (ASHP) reported in early December.
Roche’s Genentech has brand-name Tamiflu on tap and is “reviewing orders,” ASHP noted. Generic makers Ajanta, Alembic and Alvogen still have doses available, too.
Meanwhile, the affected drugmakers “did not provide a reason for the shortage,” according to ASHP’s drug shortage database.
